title: Cryptococcosis in patients living with hepatitis C and B viruses.
abstract: Cryptococcosis, a systemic fungal infection, has become a significant, global public health problem. Patients with liver disease have an increased predisposition to infections, such as Cryptococcosis. To report the underlying disease, the variety of etiologic agents involved and the outcomes of the Cryptococcosis in patients living with HBV and/or HCV, we reviewed 34 medical records of patients who were diagnosed with Cryptococcosis by the Mycology Laboratory of Santa Casa Hospital, Porto Alegre, Brazil. Males corresponded to 79% of the patients, and the average patient age was 46.9 years. The cultures of 26/34 patients were positive: 25 patients were infected with Cryptococcus neoformans and one with C. gattii. A total of 14 deaths (41%) occurred. As a criterion of our study, all patients had viral hepatitis infection: 27 (80%) were infected with HCV, five (15%) were infected with HBV, and two patients were infected with both viruses. Because HBV and/or HCV are transmitted among drug users through infected blood, and the end-stage cirrhotic liver must be transplanted, these two population types were well represented in this study and were analyzed in detail. Cryptococcosis patients living with HCV and/or HBV appear to have the same symptoms, mean age and gender distribution as the general Cryptococcosis population. Once Cryptococcosis affects the brain, a high mortality rate ensues; therefore, physicians must be aware of the possible occurrence of this disease in patients living with HCV and HBV.
authors.affiliation: Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul, Avenida Bento Gonçalves 9500, 43421, Setor 4, Porto Alegre, RS, 91501-970, Brazil, nandaspies@gmail.com.
authors.forename: Fernanda Sá
authors.initials: FS
authors.lastname: Spies
authors.forename: Markus Berger
authors.initials: MB
authors.lastname: de Oliveira
authors.forename: Monique Siebra
authors.initials: MS
authors.lastname: Krug
authors.forename: Cecilia Bittencourt
authors.initials: CB
authors.lastname: Severo
authors.forename: Luiz Carlos
authors.initials: LC
authors.lastname: Severo
authors.forename: Marilene Henning
authors.initials: MH
authors.lastname: Vainstein
mesh_terms: D000328:Adult; D000368:Aged; D001938:Brazil / Q000453:epidemiology; D003453:Cryptococcosis / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology*; D003454:Cryptococcus / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology; D005260:Female; D006509:Hepatitis B / Q000150:complications* / Q000453:epidemiology; D006526:Hepatitis C / Q000150:complications* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged